Entity
  • Heidelberg Epignostix GmbH

    Created in 2022
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    540
  • Activities

  • Technologies

  • Entity types

  • Location

    69 Heidelberg, Germany

    Heidelberg

    Germany

  • Employees

    Scale: 2-10

    Estimated: 5

  • Engaged corporates

    1
    0 0
  • Added in Motherbase

    3 months, 1 week ago
Description
  • Value proposition

    Improving diagnostic accuracy for cancer patients

    We combine world-leading scientific and medical expertise with cutting-edge technical innovation, to improve diagnostic accuracy and enhance clinical care for cancer patients.
    The company has developed its expertise since its establishment in 2022, building on decades of combined experience of its founders. We conduct research and development, certification and marketing of software solutions for molecular tumour classification based on DNA methylation profiling and machine learning.



    Epigenetics, CNS tumours, Brain tumours, Pathology, and Precision medicine

Corporate interactions BETA
Corporate TypeTweets Articles
HTGF | High-Tech Gründerfonds
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
Other

30 Jun 2024


Similar entities
Loading...
Loading...
Social network dynamics